Pankaj Kumar Panda: Improving Access to Clinical Trials for Advanced Solid Tumours
Pankaj Kumar Panda, Senior Researcher at National Cancer Centre Singapore, shared a post on X:
“Privileged and honoured to present our work on Improving Access to Clinical Trials and Novel Therapeutics for Advanced Solid Tumours (ASTER Study) on behalf of APODDC at ESMOTATAsia25.
Grateful for ESMO Merit Travel Grant!”
Herbert Loong, Chair-Elect of the International Affairs Committee and the Track Leader for Sarcoma (2023) at the American Society of Clinical Oncology (ASCO), shared Pankaj Kumar Panda’s post on X, adding:
“Amazing work presented by Pankaj Kumar Panda led by Tira Tan of Duke-NUS Medical School on behalf of APODDC!
So happy to see how international collaborations of like-minded stakeholders can generate meaningful and impactful data.
Thanks everyone for your support!”
More posts featuring the ESMO Merit Travel Grant on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023